EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments

Anuska V Andjelkovic, Muyu Situ iD, Ali Francisco Citalan-Madrid, Svetlana M Stamatovic iD, Jianming Xiang, Richard F Keep iD

Stroke · 2023-03 · 54 (3) · 661-672

DOI: 10.1161/strokeaha.122.040578 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stroke, 2023-03. Verfasst von Anuska V Andjelkovic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology (A.V.A., A.F.C.-M., S.M.S.), University of Michigan Medical School, Ann Arbor. Hauptthemen laut MEDLINE: Alzheimer Disease, Cerebral Amyloid Angiopathy. Die Arbeit wurde bisher 188-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral endothelial cells and their linking tight junctions form a unique, dynamic and multi-functional interface, the blood-brain barrier (BBB). The endothelium is regulated by perivascular cells and components forming the neurovascular unit. This review examines BBB and neurovascular unit changes in normal aging and in neurodegenerative disorders, particularly focusing on Alzheimer disease, cerebral amyloid angiopathy and vascular dementia. Increasing evidence indicates BBB dysfunction contributes to neurodegeneration. Mechanisms underlying BBB dysfunction are outlined (endothelium and neurovascular unit mediated) as is the BBB as a therapeutic target including increasing the uptake of systemically delivered therapeutics across the BBB, enhancing clearance of potential neurotoxic compounds via the BBB, and preventing BBB dysfunction. Finally, a need for novel biomarkers of BBB dysfunction is addressed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCerebral Amyloid AngiopathyHumansBlood-Brain BarrierEndothelial CellsAging

Stichwörter der Autor:innen

agingblood-brain barriercerebral amyloid angiopathyneurodegenerationneurovascular unitvascular dementia

Autor:innen und Institutionen

  • Department of Pathology (A.V.A., A.F.C.-M., S.M.S.), University of Michigan Medical School, Ann Arbor.
  • Department of Neurosurgery (A.V.A., J.X., R.F.K.), University of Michigan Medical School, Ann Arbor.
  • Neuroscience Graduate Program (M.S.), University of Michigan Medical School, Ann Arbor.
  • Department of Molecular and Integrative Physiology (R.F.K.), University of Michigan Medical School, Ann Arbor.

ORCID-Profile: Muyu Situ, Svetlana M Stamatovic, Richard F Keep

Förderung

  • NINDS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Andjelkovic, A. V., Situ, M., Citalan-Madrid, A. F., Stamatovic, S. M., Xiang, J., & Keep, R. F. (2023). Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments. Stroke, 54(3), 661-672. https://doi.org/10.1161/strokeaha.122.040578

Vancouver

Andjelkovic AV, Situ M, Citalan-Madrid AF, Stamatovic SM, Xiang J, Keep RF. Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments. Stroke. 2023;54(3):661-672. doi:10.1161/strokeaha.122.040578

BibTeX
@article{Andjelkovic2023,
  author = {Andjelkovic, Anuska V and Situ, Muyu and Citalan-Madrid, Ali Francisco and Stamatovic, Svetlana M and Xiang, Jianming and Keep, Richard F},
  title = {Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments},
  journal = {Stroke},
  year = {2023},
  volume = {54},
  number = {3},
  pages = {661--672},
  doi = {10.1161/strokeaha.122.040578}
}
Kostenlos starten →